Regulation of human intestinal T-cell responses by type 1 interferon-STAT1 signaling is disrupted in inflammatory bowel disease

Neurath, 2014, Cytokines in inflammatory bowel disease, Nat. Rev. Immunol., 14, 329, 10.1038/nri3661 O'Shea, 2010, Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells, Science, 327, 1098, 10.1126/science.1178334 Strober, 2011, Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases, Gastroenterology, 140, 1756, 10.1053/j.gastro.2011.02.016 Laouar, 2005, CD70+ antigen-presenting cells control the proliferation and differentiation of T cells in the intestinal mucosa, Nat. Immunol., 6, 698, 10.1038/ni1212 Tough, 2012, Modulation of T-cell function by type I interferon, Immunol. Cell Biol., 90, 492, 10.1038/icb.2012.7 Gough, 2012, Constitutive type I interferon modulates homeostatic balance through tonic signaling, Immunity, 36, 166, 10.1016/j.immuni.2012.01.011 Nguyen, 2002, Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection, Science, 297, 2063, 10.1126/science.1074900 Teijaro, 2013, Persistent LCMV infection is controlled by blockade of type I interferon signaling, Science, 340, 207, 10.1126/science.1235214 Wilson, 2013, Blockade of chronic type I interferon signaling to control persistent LCMV infection, Science, 340, 202, 10.1126/science.1235208 Odorizzi, 2013, Immunology. An interferon paradox, Science, 340, 155, 10.1126/science.1237568 Cho, 2014, The role of type I interferons in intestinal infection, homeostasis, and inflammation, Immunol. Rev., 260, 145, 10.1111/imr.12195 McFarland, 2011, Localized delivery of interferon-β by Lactobacillus exacerbates experimental colitis, PLoS One, 6, e16967, 10.1371/journal.pone.0016967 Abe, 2007, Conventional dendritic cells regulate the outcome of colonic inflammation independently of T cells, Proc. Natl. Acad. Sci. USA, 104, 17022, 10.1073/pnas.0708469104 Bleich, 2009, CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction, Gastroenterology, 136, 278, 10.1053/j.gastro.2008.09.022 Kole, 2013, Type I IFNs regulate effector and regulatory T cell accumulation and anti-inflammatory cytokine production during T cell-mediated colitis, J. Immunol., 191, 2771, 10.4049/jimmunol.1301093 Lee, 2012, Type I interferons maintain foxp3 expression and T-regulatory cell functions under inflammatory conditions in mice, Gastroenterology, 143, 145, 10.1053/j.gastro.2012.03.042 Radulovic, 2012, CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential, J. Immunol., 188, 2001, 10.4049/jimmunol.1100765 Axtell, 2010, T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis, Nat. Med., 16, 406, 10.1038/nm.2110 Jostins, 2012, Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease, Nature, 491, 119, 10.1038/nature11582 Seow, C.H., Benchimol, E.I., Griffiths, A.M. & Steinhart, A.H. Type I interferons for induction of remission in ulcerative colitis. Cochrane Database Syst. Rev. CD006790, 16 (2008). Teles, 2013, Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses, Science, 339, 1448, 10.1126/science.1233665 Afkarian, 2002, T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells, Nat. Immunol., 3, 549, 10.1038/ni794 Neurath, 2002, The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease, J. Exp. Med., 195, 1129, 10.1084/jem.20011956 Kelsen, 2005, FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease, Clin. Exp. Immunol., 141, 549, 10.1111/j.1365-2249.2005.02876.x Hofmann, 2010, T cell-dependent protective effects of CpG motifs of bacterial DNA in experimental colitis are mediated by CD11c+ dendritic cells, Gut, 59, 1347, 10.1136/gut.2009.193177 Wang, 2007, Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells, Eur. J. Immunol., 37, 129, 10.1002/eji.200636435 Metidji, 2015, IFN-α/β receptor signaling promotes regulatory T cell development and function under stress conditions, J. Immunol., 194, 4265, 10.4049/jimmunol.1500036 MacDermott, 1986, Deficient cell-mediated cytotoxicity and hyporesponsiveness to interferon and mitogenic lectin activation by inflammatory bowel disease peripheral blood and intestinal mononuclear cells, Gastroenterology, 90, 6, 10.1016/0016-5085(86)90067-3 Mudter, 2005, Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases, Am. J. Gastroenterol., 100, 64, 10.1111/j.1572-0241.2005.40615.x Lovato, 2003, Constitutive STAT3 activation in intestinal T cells from patients with Crohn's disease, J. Biol. Chem., 278, 16777, 10.1074/jbc.M207999200 Horino, 2008, Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice, Int. Immunol., 20, 753, 10.1093/intimm/dxn033 Palmer, 2009, Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function, Trends Immunol., 30, 592, 10.1016/j.it.2009.09.009 Musch, 2013, Topical treatment with the Toll-like receptor agonist DIMS0150 has potential for lasting relief of symptoms in patients with chronic active ulcerative colitis by restoring glucocorticoid sensitivity, Inflamm. Bowel Dis., 19, 283, 10.1002/ibd.23019 Norman, 2015, Disease-specific alterations in the enteric virome in inflammatory bowel disease, Cell, 160, 447, 10.1016/j.cell.2015.01.002 Nguyen, 2000, Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox, Nat. Immunol., 1, 70, 10.1038/76940 Mahida, 1997, Migration of human intestinal lamina propria lymphocytes, macrophages and eosinophils following the loss of surface epithelial cells, Clin. Exp. Immunol., 109, 377, 10.1046/j.1365-2249.1997.4481346.x Hart, 2005, Characteristics of intestinal dendritic cells in inflammatory bowel diseases, Gastroenterology, 129, 50, 10.1053/j.gastro.2005.05.013 Bell, 2001, Migration and maturation of human colonic dendritic cells, J. Immunol., 166, 4958, 10.4049/jimmunol.166.8.4958